Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,800
Closed -$210K 13201
2025
Q1
$210K Sell
1,800
-200
-10% -$24.4K ﹤0.01% 10354
2024
Q4
$240K Sell
2,000
-1,100
-35% -$133K ﹤0.01% 10114
2024
Q3
$330K Sell
3,100
-300
-9% -$29.7K ﹤0.01% 9136
2024
Q2
$321K Sell
3,400
-100
-3% -$10.4K ﹤0.01% 8997
2024
Q1
$387K Buy
3,500
+1,878
+116% +$175K ﹤0.01% 8926
2023
Q4
$140K Sell
1,622
-3,900
-71% -$296K ﹤0.01% 10484
2023
Q3
$388K Buy
5,522
+3,300
+149% +$230K ﹤0.01% 8620
2023
Q2
$148K Buy
2,222
+900
+68% +$54.6K ﹤0.01% 10363
2023
Q1
$78.1K Sell
1,322
-593
-31% -$34K ﹤0.01% 11592
2022
Q4
$89.9K Buy
+1,915
New +$80.1K ﹤0.01% 11365

Other funds holding ESAB

Citadel Advisors's ESAB Position: Q1 2026 in Review

Citadel Advisors sold out of ESAB (ESAB) in Q1 2026, closing a stake of 160,171 shares — an estimated $17.9M sold.

Citadel Advisors first reported a position in ESAB in Q2 2022 and held it in 13 quarters. The position peaked at $17.9M in Q4 2025. 349 funds tracked by Wall St. Rank hold ESAB as of Q1 2026.

  • Citadel Advisors reported no remaining ESAB position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 160,171 ESAB shares in Q1 2026, an estimated $17.9M.
  • Citadel Advisors first reported a position in ESAB in Q2 2022 and held it in 13 quarters.
  • Citadel Advisors's ESAB position peaked at $17.9M in Q4 2025.
  • 349 funds tracked by Wall St. Rank held ESAB as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.